TV D22 (Deferasirox 90 mg)
Pill with imprint TV D22 is Blue, Elliptical/Oval and has been identified as Deferasirox 90 mg. It is supplied by Teva Pharmaceuticals USA, Inc.
Deferasirox is used in the treatment of iron overload; thalassemia; hemosiderosis and belongs to the drug class chelating agents. Risk cannot be ruled out during pregnancy. Deferasirox 90 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TV D22
Deferasirox
- Imprint
- TV D22
- Strength
- 90 mg
- Color
- Blue
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Chelating agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
- 00093-3517 (Discontinued)
More about deferasirox
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (4)
- Drug images
- Pricing & coupons
- En español
- Drug class: chelating agents
Patient resources
- Drug Information
- Deferasirox (Advanced Reading)
- Deferasirox Sprinkle Granules
- Deferasirox Tablets
- Deferasirox Tablets For Oral Suspension
- Other brands
- Jadenu, Exjade, Jadenu Sprinkle
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.